Cannabis in Lesotho

Lesotho became the first African country to grant a license for the cultivation of medical cannabis in 2017, positioning the small, landlocked kingdom as a pioneer in African cannabis regulation. The country's favorable climate, altitude, and abundant sunshine create excellent growing conditions for cannabis, and the government has promoted cannabis cultivation as an economic development strategy for this developing nation.

Several international cannabis companies have obtained cultivation licenses in Lesotho, attracted by the low labor costs, favorable climate, and potential for large-scale outdoor cultivation. Companies from Canada, South Africa, and other countries have established operations, though the pace of development and export has been slower than initially projected. EU-GMP certification has been a particular challenge for Lesotho-based operations, as the country's infrastructure and institutional capacity create obstacles to meeting pharmaceutical-grade production standards.

Lesotho's cannabis regulatory framework is administered by the Ministry of Health, which issues licenses for cultivation, manufacturing, and export. The country has positioned itself as an export-oriented production hub, as the domestic market is negligible given its small population of 2.3 million and limited healthcare infrastructure. The primary target markets for Lesotho-produced cannabis are European and other international medical markets.

Despite its first-mover advantage in African cannabis licensing, Lesotho has faced challenges in converting licenses into commercial success. Infrastructure limitations, regulatory capacity constraints, and competition from other African and global producers have moderated expectations. The country remains an interesting case study in cannabis as an economic development tool for developing nations.